| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Abernethy Matt is a Chief Financial Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $6.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 24, 2020 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sell | 1,934 | $99.52 | $192,466.85 | -20.1% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sell | 2,030 | $103.35 | $209,806.59 | -26.3% | |
| Dec 2, 2019 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sell | 1,645 | $116.33 | $191,360.38 | -29.8% | |
| Dec 3, 2018 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sell | 1,178 | $90.00 | $106,019.65 | -37.7% |